ClinVar Miner

Submissions for variant NM_003172.4(SURF1):c.312_321delinsAT (p.Pro104_Leu105insTer) (rs863224228)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000197023 SCV000252354 pathogenic not provided 2017-01-26 criteria provided, single submitter clinical testing The c.312_321del10insAT variant in the SURF1 gene is one of the most common pathogenic variants identified in patients with Leigh syndrome associated with COX deficiency (Wedatilake et al., 2013). The c.312_321del10insAT variant results in the deletion of 10 nucleotides and insertion of 2 nucleotides, which changes the codon Leucine 105 to a premature Stop codon, denoted p.L105X. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.312_321del10insAT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.312_321del10insAT as a pathogenic variant.
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine RCV000235063 SCV000292355 pathogenic Leigh syndrome 2015-08-18 criteria provided, single submitter research This variant is predicted deleterious according to ACMG guidelines. Identified with another predicted deleterious variant, in an individual with Leigh syndrome and peripheral neuropathy. Parents were not available for segregation; however, given the similarity of the phenotypic presentation to that reported in the literature, it is likely that two variants in SURF1 are causing the phenotype in this individual.
Invitae RCV000235063 SCV000627065 pathogenic Leigh syndrome 2019-01-07 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Leu105*) in the SURF1 gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been reported as homozygous or heterozygous in combination with another SURF1 variant in many individuals affected with Leigh syndrome (PMID: 9837813, 18804471, 23829769). This variant is also known as c.312del10,insAT in the literature. ClinVar contains an entry for this variant (Variation ID: 215237). Experimental studies have shown that this nonsense change decreases complex IV activity and oxygen consumption (PMID: 18804471). Loss-of-function variants in SURF1 are known to be pathogenic (PMID: 10443880, 22488715). For these reasons, this variant has been classified as Pathogenic.
Integrated Genetics/Laboratory Corporation of America RCV000235063 SCV000698177 pathogenic Leigh syndrome 2017-05-15 criteria provided, single submitter clinical testing Variant summary: The SURF1 c.312_321delinsAT (p.Leu105Terfs) variant results in a premature termination codon, predicted to cause a truncated or absent SURF1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. p.Gln251X, c.758_759delCA, c.845_846delCT, etc.). This variant is absent in 121016 control chromosomes from ExAC. This variant is the most common pathogenic variant in Caucasian Leigh syndrome cohorts (Lee_2012, Wedatilake_2013, Lim_2014). Numerous patients carrying this variant in homozygous state as well as compound heterozygous state with other pathogenic/likely pathogenic variants have been identified, including reports of cosegregation in families carrying this variant. Biochemical enzymatic analysis in patient cells carrying this variant are show impaired enzymatic activity (Tiranti_1998, Lim_2014). In addition, multiple clinical diagnostic laboratories/reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.
Fulgent Genetics,Fulgent Genetics RCV000763191 SCV000893803 pathogenic Leigh syndrome; Charcot-Marie-Tooth disease, type 4k 2018-10-31 criteria provided, single submitter clinical testing
OMIM RCV000013596 SCV000033843 pathogenic Mitochondrial complex IV deficiency 2000-02-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.